RANDOMIZED CONTROLLED TRIAL
Add like
Add dislike
Add to saved papers

Sexual function after Bartholin gland abscess treatment: A randomized trial of the marsupialization and excision methods.

OBJECTIVE: To compare sexual function scores in patients who had marsupialization and gland excision procedures for the treatment of Bartholin gland abscesses.

STUDY DESIGN: Patients who had bartholin abscess for the first time were randomized into marsupialization or gland excision methods. The primary outcome was to compare post surgical Female Sexual Function Index (FSFI) scores between the marsupialization group and the excision group. Secondary outcomes were to calculate the recurrence rates and other postoperative complications after the surgery.

RESULTS: 195 women were evaluated for the treatment of Bartholin abscess and 154 of them were included in our study. The final analysis was carried out on 134 participants. There was no statistically significant difference among the study groups in terms of age, BMI, gravidity, parity, site of the abscess, and diameter of the abscess. The mean diameter of the abscess was not significantly different among patients who had dyspareunia (4 ± 1.34 cm) and did not have dyspareunia (3.39 ± 0.99 cm). No recurrence was observed in the gland excision group while 5 patients had a recurrence of the abscess in the marsupialization group. Dyspareunia after the procedure was more common in patients who underwent marsupialization (2.9% vs 15.1%, p = 0.01). The FSFI scores were <26.5 in both treatment groups. The total score was 24.76 ± 4.32 in the excision group and was 22.33 ± 5.15 in the marsupialization group.

CONCLUSION: The excision of the gland for treating the Bartholin abscess resulted in less dyspareunia and recurrence when compared to the marsupialization procedure. Lower FSFI scores were reported in both groups, however, FSFI scores in the excision group were higher than in the marsupialization group. The excision of the Bartholin gland did not hamper sexual function.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app